City

Chicago (2)

Overall Status

Completed (2)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

University of Chicago (1)

University of Illinois at Chicago (1)

Collaborator

Intervention

atg (1)

campath (1)

fludarabine (1)

fludarabine/ melphalan (1)

fludarabine/busulfan (1)

melphalan (1)

stem cells (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

malignant lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/

Completed

Acute Myeloid Leukemia
+10 more

fludarabine/busulfan
+2 more

Chicago, Illinois

University of Illinois at Chicago Medical Center

Oct 9, 2018

Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem

Completed

Acute Myelogenous Leukemia
+8 more

Fludarabine
+3 more

Chicago, Illinois

The University of Chicago

Oct 7, 2016